URGN
#1961
UroGen Pharma Ltd. - Ordinary Shares
43.6 2 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.13%
Variación mensual
+8.18%
Variación en los últimos 6 meses
+101.39%
Cambio anual
+129.58%
Cierres anteriores
45.5 0
Open
43.6 2
Mínimo
43.6 2
Máximo
43.6 2
Volumen
64
Financials
- Market Capitalization 2.13 B
- Employee 291
- Founded 2004
- CEO N/A
- Website www.urogen.com
- Headquarter Israel
- FIGI N/A
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.34
Relación precio/flujo de caja
11.93
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1941 |  SRPT Sarepta Therapeutics, Inc. - Common Stock | 20.86 USD | -3.38% | +12.39% | +34.23% | +15.57% | 2.20 B USD | ||
| 1948 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.29 USD | -1.15% | -1.69% | +7.88% | +36.55% | 2.17 B USD | ||
| 1972 |  VCEL Vericel Corporation - Common Stock | 40.95 USD | -0.56% | -4.05% | -16.26% | +12.65% | 2.10 B USD | ||
| 1975 |  ADMA ADMA Biologics Inc - Common Stock | 9.34 USD | -1.48% | -4.69% | +9.62% | -45.35% | 2.09 B USD |